Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
This image is advertising the OBN Digital Briefing: An Insight into the National Security and Investment Bill

The government has put forward it's National Security and Investment Bill to ensure that the government has the necessary powers to scrutinise and intervene in business transactions, such as takeovers and investments that might raise national security issues, while providing businesses and investors with the certainty and transparency they need to do business in the UK. The new law (and the ongoing consultation on the definition of the sectors that will require mandatory notification) is extremely wide and will have far-reaching consequences for the life sciences industry in the UK.

About Taylor Wessing:

Taylor Wessing is a global law firm that serves the world's most innovative people and businesses.

Our Life Sciences and Healthcare teamwork with some of the largest pharmaceutical, biotechnology and medical device companies and healthcare providers in the world to a diverse collection of small-to-medium-sized start-up enterprises ready to up-scale their business, and many companies in between. We guide ambitious global clients within these dynamic and innovative industries through the maze of connected legal, commercial, and regulatory challenges.

To register, click here